CD9 and precursor B-cell acute lymphoblastic leukemia: In a recent study involving 153 childhood B-ALL patients treated at a single-center, we reported that CD9 positivity was associated with inferior survival and, when combined with established risk factors such as prednisone response and cytogenetic status, could identify patients at high risk of relapse [21].